Health is a basic human right and one of the prosperity elements. However, in its implementation, health services are still not relatively optimal, notably for people living in underdeveloped, border, and island regions. This study primarily aimed to examine the performance of clinical pharmacy services based on the rules of the Indonesian Minister of Health Number 74 of 2016 concerning pharmaceutical service standards in the community health center. This study applied a descriptive-correlative model with a quantitative approach carried out in all Sebatik Island community health centers. All data were analyzed based on seven aspects of clinical pharmacy services consisting of assessment and prescription services, drug information service, counseling, patient visit, drug side effects monitoring, drug therapy monitoring, and the use of medical evaluation. Data collection was conducted by observation using a list of viewers, questionnaires, and interviews, equipped with retrospective data through documentary examination to give a clear depiction. The results of this study showed that the performance of clinical pharmacy services at Sebatik Island community health centers was as follows: zero aspect (0%) was at very high criteria, two aspects (29%) were at high criteria, zero aspect (0%) was at medium criteria, two aspects (29%) were at low criteria, and three aspects (43%) were at very low criteria. The average performance of clinical pharmacy services due to the seven aspects was 52% or considered in low level.
Cite this article:
MT Ghozali, Erfan Abdissalam. The Evaluation of Clinical Pharmacy services Performance at Community Health centers of sebatik island regency of Nunukan province of north Kalimantan (Indonesia-Malaysia Border). Research J. Pharm. and Tech. 2020; 13(7): 3187-3192. doi: 10.5958/0974-360X.2020.00564.8
MT Ghozali, Erfan Abdissalam. The Evaluation of Clinical Pharmacy services Performance at Community Health centers of sebatik island regency of Nunukan province of north Kalimantan (Indonesia-Malaysia Border). Research J. Pharm. and Tech. 2020; 13(7): 3187-3192. doi: 10.5958/0974-360X.2020.00564.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-7-24
1. Handayani PW, Hidayanto AN, Sandhyaduhita PI, Kasiyah, Ayuningtyas D. Strategic hospital services quality analysis in Indonesia. Expert Systems with Applications. 2015 Apr; 42(6):3067–78.
2. Dewi IK, Hardin, Sampara S, Baharuddin H, Nuh MS, Andara D, et al. Implementation of public services with a legal system approach in the “welfare state” framework to overcome disasters. IOP Conf Ser: Earth Environ Sci. 2019 Feb 20; 235:012025.
3. Tahir MT, Amiruddin R. Implementation oZf Pharmaceutical Care In Resolving Drug Problems In Type 2 Diabetes Mellitus. 2015;51(2):6.
4. Andayani TM, Satibi S. Pharmacy Practice in Indonesia. In: Pharmacy Practice in Developing Countries [Internet]. Elsevier; 2016 [cited 2019 Sep 19]. p. 41–56. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128017142000034
5. Estim A, Sudirman R. Types and abundance of macro- and micro-marine debris at Sebatik Island, Tawau, Sabah. Borneo Journal of Marine Science and Aquaculture (BJoMSA) [Internet]. 2017 Dec 11 [cited 2019 Sep 19]; Available from: https://jurcon.ums.edu.my/ojums/index.php/BJoMSA/article/view/992
6. Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018 Jul;52(4):1893–907.
7. Svarstad BL, Bultman DC, Mount JK. Patient Counseling Provided in Community Pharmacies: Effects of State Regulation, Pharmacist Age, and Busyness. Journal of the American Pharmacists Association. 2004 Jan;44(1):22–9.
8. Bond CA, Raehl CL, Franke T. Clinical Pharmacy Services, Pharmacist Staffing, and Drug Costs in United States Hospitals. Pharmacotherapy. 1999 Dec;19(12):1354–62.
9. Triller DM, Clause SL, Briceland LL, Hamilton RA. Resolution of drug-related problems in home care patients through a pharmacy referral service. American Journal of Health-System Pharmacy. 2003 May 1;60(9):905–10.
10. Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, et al. Antiepileptic drugs best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008 Jul;49(7):1239–76.
11. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription Drug Monitoring Programs and Death Rates from Drug Overdose. Pain Med. 2011 May;12(5):747–54.
12. Chiang AP, Butte AJ. Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses. Clin Pharmacol Ther. 2009 Nov;86(5):507–10.